Search
NewAmsterdam Pharma Company NV
NAMSAdd to Watchlist
20.140USD
+0.170+0.85%
Close 11-13 16:00（ET）
2.41BMarket Cap
LossP/E TTM
Today
+0.85%
5 Days
+6.56%
1 Month
+0.65%
6 Months
-45.39%
Year to Date
-42.59%
1 Year
-47.48%
Key Figures
19.930Open
20.760High
150.84KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.13%Turnover Ratio
19.970Prev. Close
19.310Low
3.03MTurnover
LossP/E Static
3.82P/B
0.00%Div Yield TTM
-27.43%ROA
42.20552wk High
0.06Volume Ratio
-241.60MNet Profit
119.54MShares
-1.7787EPS TTM
0.08Beta
-29.49%ROE
17.90052wk Low
7.26%Amplitude
100.00%Gross Margin
2.41BMarket Cap
-2.69Reward/Risk
3.40%Risk Rate
More news coming soon, stay tuned...
NewAmsterdam Pharma Company NV's Score
0.01vs previous score
Forecast8.71
Financial Health7.95
Technical4.30
Valuation Dimensions8.40
Institutional Confidence10.00
Risk Assessment5.07
Media Coverage
Coverage Level
Very Low
Very High
No data
Analyst Rating
NewAmsterdam Pharma Company NV Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.14/-0.51
Revenue / Forecast
19.16M/7.34M
NewAmsterdam Pharma Company NV Profile
SectorBiotechnology & Medical Research
Ticker SymbolNAMS
Number of employees68
CountryNetherlands
Ownership
| Shareholders | Proportion |
|---|---|
| Frazier Life Sciences Management, L.P. | 14.49% |
| Capital World Investors | 8.54% |
| RA Capital Management, LP | 8.17% |
| Forbion Capital Partners | 7.87% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 29.84% |
| Investment Advisor/Hedge Fund | 20.74% |
| Venture Capital | 19.33% |
| Private Equity | 14.49% |
Related Instruments
+1.26%
+0.79%
+0.20%
+0.55%
+0.16%
+0.04%
-0.30%
+0.08%
+2.41%
+0.21%
-0.74%
+1.78%
+2.39%
-0.19%
+0.52%
+0.45%
-3.45%
+1.47%
+1.06%
-2.17%
FAQs
What is the current price of NewAmsterdam Pharma Company NV (NAMS)?
The current price of NewAmsterdam Pharma Company NV (NAMS) is 20.14.
What is the symbol of NewAmsterdam Pharma Company NV?
The ticker symbol of NewAmsterdam Pharma Company NV is NAMS.
What is the 52-week high of NewAmsterdam Pharma Company NV?
The 52-week high of NewAmsterdam Pharma Company NV is 42.20.
What is the 52-week low of NewAmsterdam Pharma Company NV?
The 52-week low of NewAmsterdam Pharma Company NV is 17.90.
What is the market capitalization of NewAmsterdam Pharma Company NV?
The market capitalization of NewAmsterdam Pharma Company NV is 2.41B.
Is NewAmsterdam Pharma Company NV (NAMS) currently rated as Buy, Hold, or Sell?
According to analysts, NewAmsterdam Pharma Company NV (NAMS) has an overall rating of Buy, with a price target of 51.21.
What is the Earnings Per Share (EPS TTM) of NewAmsterdam Pharma Company NV (NAMS)?
The Earnings Per Share (EPS TTM) of NewAmsterdam Pharma Company NV (NAMS) is -1.78.